Literature DB >> 300468

Von Willebrand's disease: combined qualitative and quantitative abnormalities.

H R Gralnick, Y Sultan, B S Coller.   

Abstract

Studies of von Willebrand's disease typically show either a quantitative or a qualitative abnormality of the factor VIII/von Willebrand factor protein. In studies of five patients we found a combination of quantitative and qualitative defects. Quantitative abnormalities included decreased levels of procoagulant, antigen and von Willebrand factor activities in the plasma and in the column fractions of cryopercipitate from gel chromatography. Qualitative abnormalities included annormal migration or shape of the crossed antigen-antibody arcs, disproportionate reduction of von Willebrand factor in relation to antigen, altered gel elution patterns of procoagulant, and von Willebrand factor activities the negative carbohydrate stain of the VIII protein on polyacryl-amide-gel electrophoresis and, in two patients, a decreased sialic acid content of factor VIII protein. Our studies indicate that von Willebrand's disease comprises both quantitative and qualitative defects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300468     DOI: 10.1056/NEJM197705052961802

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  14 in total

1.  Biography of Barry S. Coller.

Authors:  Christen Brownlee
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

2.  Factor VIII, von Willebrand's disease, and atherosclerosis.

Authors: 
Journal:  Br Med J       Date:  1977-11-12

Review 3.  Platelet responses in health and disease.

Authors:  M I Barnhart
Journal:  Mol Cell Biochem       Date:  1978-12-22       Impact factor: 3.396

4.  [Glycoproteins: their biological and clinical significance. II (author's transl)].

Authors:  E Köttgen; C Bauer; W Reutter; W Gerok
Journal:  Klin Wochenschr       Date:  1979-03-01

5.  Structural analysis of factor VIII antigen in von Willebrand disease.

Authors:  R L Nachman; E A Jaffe; C Miller; W T Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

6.  Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.

Authors:  H R Gralnick
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

7.  [A variant of the von Willebrand-Jürgens-syndrome with abnormalities of the factor VIII/von Willebrand factor protein (author's transl)].

Authors:  K Hasler; D Böttcher; R Engelhardt
Journal:  Blut       Date:  1979-01-22

8.  Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.

Authors:  T S Zimmerman; R Voss; T S Edgington
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

9.  The platelet: life on the razor's edge between hemorrhage and thrombosis.

Authors:  Barry S Coller
Journal:  Transfusion       Date:  2014-08-05       Impact factor: 3.157

10.  Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands.

Authors:  Lesley G Ellies; David Ditto; Gallia G Levy; Mark Wahrenbrock; David Ginsburg; Ajit Varki; Dzung T Le; Jamey D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.